p27は,サイクリン依存キナーゼ4をアロステリックに活性化し,パルボシクリブ抑制を逆行させる
Keelan Z Guiley1,2, Jack W Stevenson2, Kevin Lou2
1Department of Chemistry and Biochemistry, University of California, Santa Cruz, CA 95064, USA.
まとめ
リン酸化p27タンパク質はCDK4を活性化し,細胞増殖を促進する. この活性化された複合体は,非活性CDK4/ 6を標的とする薬剤パルボシクリブに耐性を持ち,がんにおける新たなメカニズムを明らかにしています.
科学分野:
- 分子生物学
- 細胞サイクル規制
- ガン治療薬
背景:
- p27タンパク質は通常,細胞増殖を制御するサイクリン依存キナーゼ (CDKs) を阻害する.
- 活性CDK4とp27が結合するメカニズムは不明である.
- CDKの調節を理解することは,がん治療において極めて重要です.
研究 の 目的:
- p27によるCDK4活性化のメカニズムを解明する.
- p27のリン酸化による構造的および機能的影響を調査する.
- CDK4/ 6阻害剤に対するp27- CDK4複合体の感受性を決定する.
主な方法:
- タイロシンキナーゼを用いたタンパク質リン酸化試験
- タンパク質複合体の構造分析
- バイオケミカルアッセイで キナーゼの活性を測定する
- パルボシクリブによる薬剤感受性検査
主要な成果:
- リン酸化p27 (phosp27) は,サイクリンD1 (CDK4- CycD1) と複合して,アロステリックにCDK4を活性化させる.
- レチノブラストーマタンパク質 (Rb) のような基質のリン酸化を高め,CDK4活性部位を変化させます.
- 薬剤は単体CDK4/ 6を標的とする一方,フォス27- CDK4- CycD1複合体はパルボシクリブに対して無感性である.
結論:
- 酸化されたp27は,独特の調節特性を持つ活性Rbキナーゼ複合体 (phosp27-CDK4-CycD1) を形成する.
- この複合体はCDK4/ 6の新型薬剤耐性活性を表しています.
- 発見は,がんにおける抵抗性CDK4/ 6複合体を標的とした新しい治療戦略を示唆する.
さらに関連する動画
関連する概念動画
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Negative Regulator Molecules
38.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.1K
Positive Regulator Molecules
6.4K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
6.4K
Positive Regulator Molecules
133.4K
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
133.4K
Anaphase Promoting Complex
3.3K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.3K
Interactions Between Signaling Pathways
7.1K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K


